The research team, led by Cheng Qixiu and Hao Chen at Anhui Agricultural University in Hefei, China, together with colleagues including corresponding authors Xiaoyu Li and Jin Chen, focused on the rhizosphere, the narrow zone of soil immediately surrounding and influenced by plant roots. This hotspot of biological activity is where roots release sugars, organic acids, and other exudates that feed microbes, and where microbes in turn mineralize nutrients that the plant can absorb. While previous work had established that plant development shapes rhizosphere communities in crops such as rice and maize, how the bacterial and fungal associates of A. lavandulifolia shift across its phenological stages remained largely unexplored.

To close that gap, the researchers used high-throughput sequencing to characterize rhizosphere bacterial and fungal communities at two distinct developmental points: the early vegetative stage (EVS) and the late vegetative stage (LVS). Sequencing reveals which organisms are present and in what relative proportions, but it cannot say how many of them there are in absolute terms. To add that crucial dimension, the team turned to quantitative PCR, measuring the absolute abundance of bacterial 16S rRNA genes and fungal ITS genes, as well as a panel of key functional genes involved in carbon, nitrogen, and phosphorus cycling. This combination of approaches allowed them to track not just who lives in the rhizosphere, but how the community’s functional machinery scales with plant growth.

The results were striking on both fronts. Alpha diversity — the number of species and their evenness within a sample — was significantly higher in both bacterial and fungal communities at the late vegetative stage compared with the early stage, with statistical significance at p < 0.05. In other words, as the plant matured, its root zone became a richer and more varied microbial habitat. This pattern is consistent with the idea that older, larger plants pump more varied and abundant exudates into the soil, opening more ecological niches and supporting a broader cast of microbial characters.

Diversity, however, was only part of the story. Co-occurrence network analysis, which maps potential ecological relationships among microbial taxa, revealed that the architecture of the community grew dramatically more complex as the plant developed. In the bacterial networks, the number of nodes rose from 1,049 at the early stage to 1,189 at the late stage, while the number of edges — the connections between taxa — surged from 76,390 to 98,550. The fungal networks showed an even more pronounced relative expansion, with nodes increasing from 230 to 373 and edges from 4,509 to 6,932. More nodes and more edges mean more potential interactions: more cooperation, competition, and cross-feeding among microbes, and a denser web of relationships linking the community together.

Why would connectivity matter? In microbial ecology, network complexity is often read as a signature of community stability and functional integration. A densely connected community can buffer disturbances and coordinate metabolic handoffs, in which the waste product of one organism becomes the substrate of another. The authors’ data suggest that as A. lavandulifolia approaches the metabolically demanding later phase of vegetative growth — building biomass, expanding root systems, and preparing for reproduction — its rhizosphere does not simply accumulate more microbes; it rewires itself into a more intricate and potentially more resilient collective.

The most consequential findings concern function. The absolute abundances of three marker genes were significantly elevated at the late vegetative stage: cbbLR, associated with carbon fixation; amoA, which encodes a key enzyme in ammonia oxidation and thus nitrogen cycling; and phoD, which encodes alkaline phosphatase involved in phosphorus mineralization. Each of these genes represents a lever on a nutrient cycle that matters directly to the plant. Carbon fixation genes point to microbes that can draw inorganic carbon into organic form; amoA marks bacteria that transform nitrogen into plant-accessible states; and phoD flags organisms capable of unlocking phosphorus from organic compounds in the soil. That all three rose together, in absolute terms, indicates a coordinated ramping-up of the rhizosphere’s nutrient-processing capacity.

The authors interpret this coordinated shift as an adaptive adjustment: microbially mediated nutrient cycling intensifies to meet the heightened metabolic demands of the host during late vegetative growth. The logic is compelling. A larger plant demands more nitrogen for proteins, more phosphorus for nucleic acids and energy transfer, and a more active carbon economy in its root zone. Rather than the plant simply taking more from a static soil community, the community itself appears to reorganize — diversifying, interconnecting, and amplifying its functional gene repertoire — in a stage-dependent fashion. Plant ontogeny, in this view, is not a passive backdrop but an active conductor of the underground orchestra.

The study also carries practical implications. If the timing of microbial functional potential tracks plant phenology, then agricultural interventions — inoculants, fertilizers, or soil amendments — might be most effective when timed to the plant’s developmental stage rather than applied on a fixed calendar. The concept of inoculation timing, or priority effects, is a growing theme in plant microbiome research, and this work adds ecological weight to it by showing that the rhizosphere’s own assembly trajectory changes with the host. For A. lavandulifolia, a species of interest in traditional medicine and volatile-oil production, understanding these stage-specific dynamics could inform cultivation practices that harness the plant’s native microbial partners.

More broadly, the research contributes to a shifting picture of how plants and their microbiomes co-evolve through time. The rhizosphere is increasingly seen as a dynamic interface where root exudate chemistry, microbial substrate preferences, and successional processes interact. By pairing sequencing-based community profiling with quantitative PCR of functional genes, the Anhui team demonstrated that structural and functional changes in the microbiome move together across phenology — a coupling that relative-abundance data alone would have missed. As climate change and intensive agriculture place new pressures on soil ecosystems, decoding these developmental rhythms in plant-microbe partnerships may prove essential for predicting, and perhaps steering, the nutrient cycles that sustain both crops and wild vegetation. For now, the humble A. lavandulifolia has offered a vivid demonstration that a plant’s growth is a conversation with its microbes — one that grows richer with every stage of life.

Subject of Research: Phenology-driven assembly and functional gene dynamics of the Artemisia lavandulifolia rhizosphere microbiome

Article Title: Phenology-dependent assembly and functional potential of the Artemisia lavandulifolia rhizosphere microbiome

Article References: Phenology-dependent assembly and functional potential of the Artemisia lavandulifolia rhizosphere microbiome. (n.d.). https://doi.org/10.1007/s13205-026-05024-2

Image Credits: AI Generated

DOI: 10.1007/s13205-026-05024-2

Keywords: Artemisia lavandulifolia, rhizosphere, microbiome, phenology, plant growth stages, high-throughput sequencing, quantitative PCR, co-occurrence networks, nitrogen cycling, phosphorus mineralization, carbon fixation, soil microbial ecology

Wolbachia is an intracellular bacterium that manipulates the reproduction of its insect hosts, most famously through a phenomenon known as cytoplasmic incompatibility. When males carrying a particular Wolbachia strain mate with females that either lack that strain or carry a different one, their fertilized eggs fail to hatch. This quirk of reproductive biology has become the foundation of several mosquito control approaches, including the incompatible insect technique, in which large numbers of Wolbachia-carrying male mosquitoes are released to mate with wild females and crash the population. Wolbachia also has pathogen-blocking properties, meaning it can interfere with the ability of mosquitoes to transmit viruses such as dengue, which underlies replacement strategies that spread virus-resistant Wolbachia strains through wild populations.

Unlike Aedes aegypti, the yellow fever mosquito, which does not naturally harbor Wolbachia, Aedes albopictus carries two native strains of the bacterium, designated wAlbA and wAlbB. In most populations studied elsewhere, individuals are superinfected, meaning they carry both strains simultaneously. This natural dual infection matters enormously for control programs because the outcome of any cytoplasmic incompatibility-based intervention depends on which strains are already circulating in the target population. If wild mosquitoes carry unexpected combinations of strains, or if the density of the bacteria in their tissues varies in unanticipated ways, releases of incompatible males may fail to suppress reproduction as intended.

Despite the global importance of these questions, the infection status of Hawaiian Aedes albopictus had remained poorly characterized. A research team led by Sangwoo Seok and senior authors Eric P. Caragata and Yoosook Lee of the Florida Medical Entomology Laboratory at the University of Florida, working with collaborators from state and federal agencies in Hawaiʻi and the University of California, set out to fill this gap. Using quantitative PCR, a laboratory technique that can detect and precisely quantify the amount of bacterial DNA in an individual mosquito, the team characterized Wolbachia infections in 399 specimens collected from two islands: Oʻahu and the Island of Hawaiʻi.

The headline finding was that Wolbachia is nearly universal in these populations: 98.5 percent of the mosquitoes tested were infected. However, the composition of those infections was strikingly lopsided. Every infected specimen carried wAlbB, but only 28.6 percent were superinfected with wAlbA. In other words, the vast majority of Hawaiian Aedes albopictus carry only a single Wolbachia strain, a pattern that departs from the double infection typically assumed for this species. This lower-than-expected prevalence of wAlbA establishes an important baseline for any future biocontrol effort in the region, because it means the resident bacterial landscape is not uniform across individuals.

The study also revealed that infection dynamics are strongly shaped by the sex of the mosquito. Females were significantly more likely than males to harbor wAlbA, and bacterial density, the quantity of Wolbachia per individual, was significantly higher in females for both strains. This sex bias has practical implications because only female mosquitoes bite and transmit viruses, and because cytoplasmic incompatibility manifests through the interaction between infected males and uninfected or differently infected females. A sex-skewed distribution of native strains therefore changes the arithmetic of any release program designed around mating incompatibility.

Environmental factors also left their mark on the bacterial communities. The prevalence of wAlbA was associated with the island of collection and with precipitation at the collection site, suggesting that local climate and geography influence which mosquitoes carry the second strain. By contrast, the prevalence of wAlbB did not vary significantly with sex, island, temperature, or precipitation, indicating that the two native strains respond to different ecological pressures. Temperature is known from laboratory studies to affect Wolbachia density, and rainfall shapes breeding habitat availability, so these field associations provide a real-world counterpart to experimental work on how environmental conditions modulate symbiont infections.

Perhaps the most technically intriguing results concern the interactions between the two strains when they coexist in the same mosquito. In superinfected individuals, wAlbB consistently exhibited higher density than wAlbA, and wAlbB density was higher in superinfected mosquitoes than in those carrying wAlbB alone. Both strains reached higher densities in females than in males. In females, the densities of the two strains were positively correlated, meaning mosquitoes with more wAlbA also tended to have more wAlbB, whereas no such correlation existed in males. These sex-specific microbe-microbe dynamics suggest that the two symbionts do not simply compete for host resources; their relationship differs fundamentally between the sexes, possibly reflecting differences in tissue tropism, vertical transmission requirements, or host physiology.

For the design of Wolbachia-based control in Hawaiʻi, these findings carry a clear warning. Population suppression projects that rely on cytoplasmic incompatibility depend on predictable mating outcomes between released and wild mosquitoes. If a substantial fraction of wild females carry only wAlbB while released males carry both strains or a different combination, the strength of incompatibility may vary across the population, diluting the effectiveness of releases. Similarly, the sex and site-specific variation in bacterial density could influence how faithfully the released strains are transmitted to the next generation. The authors emphasize that future projects in the region must account for these varying patterns of infection before strategies are developed and implemented, rather than assuming a uniform superinfection across the archipelago.

The study, funded in part by the U.S. Environmental Protection Agency’s Science to Achieve Results program, the USDA National Institute of Food and Agriculture, and the National Institutes of Health, and conducted with permits from Hawaiʻi’s national parks, demonstrates the value of baseline surveillance before intervention. As Hawaiʻi confronts recurring outbreaks of dengue and the expanding range of mosquito vectors in a warming climate, understanding the invisible bacterial passengers of its mosquitoes has become a practical necessity. The nearly universal presence of wAlbB, the patchy distribution of wAlbA, and the complex density relationships between the strains together form a map of the biological terrain on which any future Wolbachia campaign will be fought, and this research provides the first careful survey of that terrain across the Hawaiian Islands.

Subject of Research: Native Wolbachia infection prevalence and density in Hawaiian Aedes albopictus mosquito populations

Article Title: Native Wolbachia infection dynamics across Aedes albopictus (Diptera: Culicidae) populations in Hawaiʻi

Article References: Seok, S., Salama, L., Vorsino, A. E., Leong, M. K. H., Haines, W. P., Jacobsen, C. M., Akbari, O. S., Caragata, E. P., & Lee, Y. (2026). Native Wolbachia infection dynamics across Aedes albopictus (Diptera: Culicidae) populations in Hawaiʻi. Parasites &amp; Vectors. https://doi.org/10.1186/s13071-026-07695-5

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07695-5

Keywords: Wolbachia, Aedes albopictus, Hawaiʻi, cytoplasmic incompatibility, mosquito control, dengue, Zika, chikungunya, endosymbiont, quantitative PCR, invasive species, vector biology

The study, published as a short commentary in the Journal of Neurology, comes from a group led by Monica Gagliardi of the Neuroscience Research Center at Magna Graecia University in Catanzaro, in the southern Italian region of Calabria. The researchers measured two molecular features in whole blood from 58 patients with Parkinson’s disease, 35 patients with multiple system atrophy, and 62 healthy controls drawn from the same region. The first feature was the copy number of mitochondrial DNA, estimated by quantifying the mitochondrially encoded NADH dehydrogenase 1 gene, known as ND1, relative to the nuclear beta-actin gene. The second was telomere length, the protective caps at the ends of chromosomes that erode with each cell division and are widely regarded as a cellular clock of aging.

The technical approach relied on quantitative PCR, the workhorse method for amplifying and measuring specific DNA sequences. By comparing the abundance of a mitochondrial gene to a single-copy nuclear gene, the team obtained a relative estimate of how many mitochondrial genomes each blood sample carries per cell. Telomere length was measured with the same technique, comparing the amount of telomeric DNA to a reference gene. To guard against spurious results, the researchers applied multivariable linear regression adjusted for age and sex, two factors known to influence both mitochondrial DNA copy number and telomere length, and they demanded that findings survive correction for multiple comparisons using false discovery rate-adjusted Wald tests, a statistical safeguard that reduces the risk of false positives when many hypotheses are tested at once.

The results were striking. Mitochondrial DNA copy number, as indexed by the ND1 gene, was significantly reduced in both patient groups compared with healthy controls, with a false discovery rate-adjusted p-value of 1.63 times ten to the power of minus twenty-two for Parkinson’s disease and 2.56 times ten to the power of minus eight for multiple system atrophy. More importantly for the question of diagnosis, the marker also separated the two diseases from each other: Parkinson’s patients showed significantly lower ND1 copy number than multiple system atrophy patients, with an adjusted p-value of 8.43 times ten to the power of minus twenty-two. In a field where biomarkers that cleanly discriminate between overlapping neurodegenerative conditions are desperately scarce, a difference of that statistical magnitude in a peripheral blood test is remarkable.

Telomere length told a related but subtly different story. Both patient groups again showed significantly shorter telomeres than the controls, with adjusted p-values of 3.21 times ten to the power of minus sixteen for Parkinson’s disease and 1.44 times ten to the power of minus twelve for multiple system atrophy. But when the researchers compared the two patient groups directly against each other, the difference was far weaker, reaching only the threshold of statistical significance with an adjusted p-value of 5.47 times ten to the power of minus two. In other words, telomere shortening appears to be a shared feature of both alpha-synucleinopathies, a general signature of accelerated cellular aging, whereas mitochondrial DNA copy number carries disease-specific information that could, in principle, help clinicians tell the two conditions apart.

Why would mitochondrial DNA copy number be depleted in the blood of patients with these brain diseases? The answer likely lies in the intimate relationship between mitochondria and neurodegeneration. Mitochondria are the organelles that generate most of the chemical energy a cell needs, and they carry their own small circular genome, separate from the DNA in the nucleus. Cells adjust the number of mitochondrial genomes they harbor in response to energy demands and stress. Decades of research have implicated mitochondrial dysfunction in Parkinson’s disease, from studies showing impaired mitochondrial respiration in the blood cells of people with early and even prodromal Parkinson’s, to work demonstrating mitochondrial defects in the fibroblasts of patients with multiple system atrophy. Previous studies have also reported reduced mitochondrial DNA copy number as a biomarker of Parkinson’s disease, although the picture is complicated: some investigations, including one in individuals of African ancestry, found increased blood-derived mitochondrial DNA copy number, and recent work has even documented elevated mitochondrial DNA copy number in the cerebellum of people with Parkinson’s. The direction and meaning of the signal may depend on tissue, disease stage, ancestry, and the specific cell populations being counted.

That last caveat is an important one. Whole blood is a mixture of cell types, and different immune cells carry different amounts of mitochondrial DNA. Recent research has suggested that differences in the abundance of peripheral immune cell populations may link blood mitochondrial DNA copy number to Parkinson’s disease, meaning that what looks like a mitochondrial defect could partly reflect shifts in blood cell composition driven by inflammation. Neuroinflammation is increasingly recognized as a player in both Parkinson’s disease and multiple system atrophy, so the reduced copy number observed in this study could reflect either genuine mitochondrial depletion within cells or an altered mix of circulating leukocytes, or both. The authors themselves frame their findings as preliminary and call for longitudinal studies in larger, independent cohorts to validate the diagnostic and prognostic utility of the marker before it could enter clinical practice.

The telomere findings also fit into a rich and sometimes contradictory literature. Telomere dysfunction is known to trigger metabolic and mitochondrial compromise through a stress-response network involving the p53 protein, creating a mechanistic bridge between the two markers measured in this study. Mouse experiments have shown that telomere shortening accelerates synucleinopathy and impairs the response of microglia, the brain’s immune cells, in genetic models of Parkinson-like disease. Human studies of leukocyte telomere length in Parkinson’s disease have produced mixed results over the years, with some groups reporting shorter telomeres in patients, others finding no difference, and longitudinal work suggesting that longer telomeres at diagnosis may paradoxically predict faster progression to dementia in idiopathic parkinsonism. A recent prospective analysis of the UK Biobank linked leukocyte telomere length to the risk of neurodegenerative diseases more broadly, reinforcing the idea that biological aging markers capture something real about vulnerability to these conditions, even if the details remain contested.

What makes the new study noteworthy is not any single result but the head-to-head comparison of the two markers within the same cohort, using the same methods and the same statistical framework. By showing that mitochondrial DNA copy number separates Parkinson’s disease from multiple system atrophy while telomere length does not, the researchers provide a concrete argument for prioritizing mitochondrial DNA copy number as a non-invasive, blood-based biomarker of disease-specific mitochondrial alterations in alpha-synucleinopathies. If the finding holds up in larger and more diverse populations, it could eventually help solve one of clinical neurology’s persistent puzzles: distinguishing Parkinson’s disease from multiple system atrophy early in the disease course, when the distinction matters most for counseling patients, planning treatment, and selecting the right participants for clinical trials of disease-modifying therapies. For now, the measurement requires nothing more exotic than a blood draw and quantitative PCR, a combination that, if validated, would make this one of the most practical biomarker candidates to emerge from the intersection of mitochondrial biology and neurodegeneration research.

Subject of Research: Mitochondrial DNA copy number and telomere length as blood biomarkers in Parkinson's disease and multiple system atrophy

Article Title: Preliminary insights into whole-blood mitochondrial DNA copy number and telomere length in Parkinson’s disease and multiple system atrophy

Article References: Preliminary insights into whole-blood mitochondrial DNA copy number and telomere length in Parkinson’s disease and multiple system atrophy. (n.d.). https://doi.org/10.1007/s00415-026-14172-7

Image Credits: AI Generated

DOI: 10.1007/s00415-026-14172-7

Keywords: Parkinson's disease, multiple system atrophy, mitochondrial DNA copy number, telomere length, alpha-synucleinopathies, biomarkers, neurodegeneration, mitochondrial dysfunction, quantitative PCR, cellular aging, blood biomarker, Journal of Neurology

The study, published in BMC Pediatrics by Martin Jouza, Petr Jabandziev, and colleagues at University Hospital Brno and Masaryk University, focused on microRNAs, or miRNAs. These are short, non-coding RNA fragments, typically around 19 to 24 nucleotides long, that do not carry instructions for building proteins. Instead, they act as fine-tuners of gene expression, binding to messenger RNA transcripts and dampening their translation. Crucially for diagnostic medicine, miRNAs are remarkably stable in body fluids, protected from degradation by their small size and by packaging inside membrane-bound vesicles or association with carrier proteins. That stability makes them attractive candidates for liquid biopsy-style biomarkers, molecules measurable from a simple blood draw rather than invasive tissue sampling.

The rationale for looking at miRNAs in sepsis is rooted in immunology. Sepsis is fundamentally a dysregulated inflammatory response to infection, and miRNAs are deeply embedded in the control of that response. Individual miRNAs regulate networks of cytokine signaling, neutrophil function, and macrophage polarization. When infection tips the immune system into overdrive, the circulating profile of these molecules shifts measurably. Previous smaller studies had hinted that specific miRNAs change in septic newborns, but independent confirmation has been scarce, and the field has repeatedly seen promising biomarker candidates fail when tested in new cohorts. The Brno team set out to provide exactly that independent test.

The researchers assembled a cohort of 64 newborns with sepsis and 21 control infants without signs of systemic infection. Within the sepsis group, 20 patients were classified as having early-onset sepsis, typically acquired around the time of birth, and 41 had late-onset sepsis, acquired later during hospitalization. Blood cultures were positive in 45 percent of cases, with Staphylococcus epidermidis, Escherichia coli, and Staphylococcus aureus standing out as the most common pathogens. From each patient, peripheral blood was collected and plasma was separated, from which total RNA enriched for small RNA species was extracted.

On the technical side, the team selected eight candidate miRNAs based on a systematic search of the existing literature: hsa-miR-29a-3p, hsa-miR-96-5p, hsa-miR-185-5p, hsa-miR-16-5p, hsa-miR-15a-5p, hsa-miR-132-3p, hsa-miR-223-3p, and hsa-miR-26a-5p. Levels of each molecule were quantified using quantitative polymerase chain reaction, the workhorse technique of nucleic acid measurement, which amplifies specific RNA sequences and allows their relative abundance to be calculated. To control for technical variation between samples, the researchers normalized the results to the average expression of all measured miRNAs, a common strategy when no single endogenous reference is reliable across inflammatory states. Statistical analysis was performed in GraphPad Prism 8.

The results were clear-cut. Of the eight miRNAs examined, three were significantly dysregulated in septic newborns compared with controls: miR-15a, miR-132, and miR-223. MiR-15a showed the most pronounced effect, with a p-value of 0.0009, indicating a difference between groups that would arise by chance less than one time in a thousand. To translate these molecular findings into something clinically usable, the team built a combined diagnostic model using logistic regression, a statistical method that weighs multiple inputs to estimate the probability that a patient belongs to one group or another. Incorporating the three most significantly dysregulated miRNAs, the model achieved an area under the curve, or AUC, of 0.78. In diagnostic terms, an AUC of 1.0 represents perfect discrimination and 0.5 represents a coin flip, so 0.78 indicates meaningful, though not definitive, diagnostic power.

Several secondary findings add depth to the picture. No significant differences in miRNA expression emerged between early-onset and late-onset sepsis, suggesting that the molecular signature reflects the septic process itself rather than the timing of infection. More intriguingly, the researchers tracked miRNA levels longitudinally. MiR-15a showed significant dysregulation during the acute phase of the disease and returned to baseline levels by day seven, behaving like a dynamic readout of the inflammatory storm rather than a static marker. When the team stratified patients by nSOFA score, a neonatal adaptation of the Sequential Organ Failure Assessment used to gauge sepsis severity, they found divergent miRNA normalization trajectories between severity subgroups. MiR-15a and miR-223 were significantly dysregulated in patients with higher nSOFA scores, hinting that these molecules could flag which infants are heading toward severe disease before the clinical picture fully declares itself.

The researchers also examined how the miRNA signals relate to C-reactive protein, or CRP, the standard inflammatory marker measured in virtually every suspected sepsis workup. CRP was systematically assessed in all patients, and correlations between CRP and miR-15a, miR-132, and miR-223 were analyzed. CRP has well-known limitations in newborns: it rises slowly after the onset of infection, can be elevated for benign reasons related to birth trauma, and lacks specificity. A biomarker panel that captures complementary information, or that responds faster than CRP, would fill a genuine clinical gap. The study’s design, pairing molecular measurements with routine CRP data, positions the miRNAs as potential partners rather than immediate replacements for existing tests.

The authors conclude that miRNAs could serve as semi-invasive biomarkers for neonatal sepsis, and they emphasize the prognostic dimension of their findings. Because miR-15a and miR-223 tracked with nSOFA-based severity, they may function as predictive biomarkers for severe disease progression, not merely diagnostic ones. In practical terms, a neonatologist armed with such a test could, in principle, stratify patients at the bedside, intensify monitoring or escalate antibiotics for infants whose molecular profile signals high risk, and personalize treatment intensity in a condition where both undertreatment and overtreatment carry serious costs. The study is also notable as the first independent evaluation of these particular miRNA findings in neonatal sepsis, addressing a reproducibility problem that has long dogged the biomarker literature.

Caution is still warranted before such a test reaches the nursery. The cohort, while well characterized, is modest in size, and the AUC of 0.78, though respectable, falls short of the near-perfect discrimination clinicians would want for a stand-alone diagnostic. Normalization strategies for circulating miRNAs remain debated, and standardization across laboratories will be essential before any clinical deployment. Still, the convergence of diagnostic signal, longitudinal dynamics, and severity correlation in a single validated panel marks real progress. If larger multicenter trials confirm these results, the humble microRNA, a molecule once dismissed as genetic noise, could become a routine part of the arsenal against one of newborn medicine’s deadliest adversaries.

Subject of Research: Circulating microRNA biomarkers for diagnosing and predicting severity of neonatal sepsis

Article Title: Dysregulated microRNA expression in neonatal sepsis: validation study of potential novel biomarkers

Article References: Jouza, M., Bohosova, J., Sonawane, S., Naar, O., Slaba, K., Stanikova, A., Slaby, O., & Jabandziev, P. (2026). Dysregulated microRNA expression in neonatal sepsis: validation study of potential novel biomarkers. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07703-8

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07703-8

Keywords: microRNA, neonatal sepsis, biomarkers, miR-15a, miR-223, nSOFA, logistic regression, quantitative PCR, C-reactive protein, neonatology, non-coding RNA, liquid biopsy